Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Aquestive Resubmits Needle-Free Sublingual Epinephrine to FDA for Approval

Potential Breakthrough for Celiac Disease: Teva Antibody Significantly Reduces Gluten-Induced Gut Damage

Rare Antibodies Could Lead to First Targeted Treatment for Alpha-Gal Syndrome

Another Potential Food Allergy Treatment is Snapped Up by Big Pharma

Microneedle Stamp for Peanut Allergy Moves Through First Human Trial

DBV Completes Phase III Study of Peanut Patch

Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results

FDA Grants Kaleo Priority Review Status for Auvi-Q Designed for Infants...

New Gene Therapy Could Retrain Immune System to 'Forget' Allergy

New Cancer Treatment May Prove Effective Against Food Allergies

Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials

Aimmune Begins Patient Enrollment for Phase III Clinical Trial of Peanut...

Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of...

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Viaskin Peanut Patch: Lasting Response After Three Years

Follow Us

Your School On Our Map

Put Your School on the Map